|

Apixaban 5 MG Clinical Trials

1 actively recruiting trial

Also known as: ELIQUIS 5mg

Pipeline

Phase 3: 1

Top Sponsors

  • University Hospital, Lille1

Indications

  • Microhaemorrhage1
  • Heart Disease1
  • Intracerebral Hemorrhage1
  • Atrial Fibrillation1

Other1 trial

Avoiding Anticoagulation After IntraCerebral Haemorrhage
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.